Table 1B.
Maternal disease and treatment during pregnancy. 5-FU: 5-Fluorouracil. FEC: 5-fluorouracil, epirubicin and cyclophosphamide. FAC: 5-fluorouracil, doxorubicin (adiamycin) and cyclophosphhamide. AC: doxorubicin and cyclophosphamide. EC: epirubicin and cyclophosphamide. ABVD: Doxorubicin, Bleomycin, Vinblastine, Dacarbazine.
| Maternal disease (n=42) | Count | % |
|---|---|---|
| Breast cancer | 25 | 60% |
| Cervical cancer | 3 | 7% |
| Ovarian cancer | 1 | 2% |
| Hodgkin Lymphoma | 3 | 7% |
| Tongue cancer | 3 | 7% |
| Leukaemia | 2 | 5% |
| Brain tumour | 2 | 5% |
| Melanoma | 1 | 2% |
| Kidney carcinoma | 1 | 2% |
| Colon cancer | 1 | 2% |
| Maternal treatment | ||
| during pregnancy (n=42) | ||
| Chemotherapy | 30 | 71% |
| Targeted therapy (Trastuzumab) | 1 | 2% |
| Radiotherapy | 5 | 12% |
| Surgery | 29 | 69% |
| No treatment | 6 | 14% |
| Chemotherapy regimen (n=30) | ||
| FEC/FAC | 11 | 37% |
| AC/EC | 7 | 23% |
| ABVD | 3 | 10% |
| Cisplatin | 3 | 10% |
| Carboplatin and 5-FU | 2 | 7% |
| 5-FU | 1 | 3% |
| Daunorubicin/Cytarabine | 1 | 3% |
| Epirubicin | 1 | 3% |
| Temozolomide | 1 | 3% |